OTC · Agricultural Farm Products

Chia Tai Enterprises International Limited (CAIHF) Stock

$0.28 +0.00% OTC: CAIHF Healthcare

Chia Tai Enterprises International Limited (CTEI) is a global entity primarily involved in the production and distribution of chlortetracycline (CTC) and its associated derivatives. The company's business activities span Mainland China, the Asia Pacific region, the Americas, Europe, and other international markets, and are organized into two principal divisions: Biochemical and Industrial.

Valuation

MetricValue
Price$0.28
Market Cap$1.16M
P/E Ratio0.02
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$0.03
52-Week High$0.28
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE11.52%
ROA4.88%
ROCE10.99%
Gross Margin15.79%
Operating Margin7.32%
Net Margin6.39%
Debt/Equity0.18
Current Ratio1.57

Annual Financials (USD)

Metric20212022202320242025
Revenue$142.0M$160.0M$174.0M$309.0M$537.0M
Operating Profit$5.0M$5.0M$-5.0M$11.0M$39.0M
Net Profit$19.0M$-7.0M$3.0M$11.0M$32.0M
EPS$0.08$-0.03$0.01$0.04$0.13
Op Margin3.5%3.1%-2.6%3.6%7.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$365.0M$350.0M$377.0M$422.0M$462.0M
Total Liabilities$82.0M$95.0M$125.0M$162.0M$154.0M
Cash$8.0M$10.0M$38.0M$8.0M$40.0M
Borrowings$43.0M$49.0M$78.0M$69.0M$48.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$6.0M$-16.0M$14.0M$34.0M
Investing Cash Flow$-38.0M$-32.0M$-18.0M$-23.0M$-9.0M
Financing Cash Flow$-2.0M$0$0$0$0
Net Cash Flow$-1.0M$0$7.0M$-5.0M$7.0M
Free Cash Flow$-18.0M$-10.0M$-27.0M$1.0M$28.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.14
EV / EBITDA7.32
FCF Yield0.00%
Quick Ratio1.33
Interest Coverage36.15
Return 1Y0.00%
Return 3Y211.11%
Return 5Y64.71%

Ownership

Insiders Held73.26%
Institutions Held0.10%
Institutions Float Held0.37%
Institutional HolderSharesReport Date
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.15,5002026-04-30
Dimensional ETF Trust-Dimensional International Core Equity 2 ETF14,5002026-04-30
American Century ETF Trust-Avantis International Small Cap Value ETF19,0002026-06-30
American Century ETF Trust-Avantis International Equity ETF13,0002026-06-30
Dimensional ETF Trust-Dimensional International Small Cap ETF11,5002026-04-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BICTFBiocure Technology Inc. $0.01 +0.00% -2.10 $379088 0.00%
BIORBiora Therapeutics, Inc. $0.22 +0.00% 0.00 $994994 0.00%
BMNDFBiomind Labs Inc. $0.15 +166.00% -12.72 $11.35M 0.00%
ENZCEnzolytics Inc. $0.00 -11.20 $2.36M 0.00%
EVFMEvofem Biosciences, Inc. $0.01 -4.76% -0.16 $1.06M 0.00%

About Chia Tai Enterprises International Limited

Chia Tai Enterprises International Limited (CTEI) is a global entity primarily involved in the production and distribution of chlortetracycline (CTC) and its associated derivatives. The company's business activities span Mainland China, the Asia Pacific region, the Americas, Europe, and other international markets, and are organized into two principal divisions: Biochemical and Industrial. The Biochemical segment concentrates on the formulation and commercialization of CTC premix and CTC hydrochloride products. These substances function as crucial feed additives for livestock, designed to foster growth, ward off or alleviate animal ailments, and enhance feed efficiency, marketed under the "Shihao" and "Citifac" brand names. In contrast, the Industrial segment encompasses the sale, rental, and maintenance services for various Caterpillar heavy equipment, including excavators, power generators, bulldozers, and compactors, alongside their corresponding spare parts. This division also undertakes the manufacturing and supply of carburetors and diverse automotive components for vehicle and motorcycle producers. Established in 1987, CTEI's headquarters are located in Central, Hong Kong, and it operates as a subsidiary of Charoen Pokphand Foods Public Company Limited.

Chia Tai Enterprises International Limited is headquartered in HK.

Chia Tai Enterprises International Limited (CAIHF) stock trades at $0.28 with a market capitalization of $1.16M. The stock is valued at a price-to-earnings (P/E) ratio of 0.02, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.28, and currently trades at its 52-week high.

On profitability, Chia Tai Enterprises International Limited generates a return on equity (ROE) of 11.52%, return on capital employed of 10.99%, an operating margin of 7.32%, a net profit margin of 6.39%.

Official website: www.ctei.com.hk

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides